Miller et al developed a risk score based on the TENOR (The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens) study. This can help to identify a patient with severe or difficult-to-treat asthma who is at risk for an ED visit or hospitalization. The authors are from Genentech, Novartis, University of California, National Jewish Medical and Research Center (Denver) and Harvard Medical School.
